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In this study, prognostic value of cerebrospinal fluid (CSF) free fatty acid (FFA) levels
in patients confirmed with acute ischemic stroke (AIS) was evaluated in a Chinese
population. A prospective cohort designed study was conducted at our hospital of
the Emergency department from November, 2012 to September, 2014. The National
Institutes of Health Stroke Scale (NIHSS) score on admission was applied to assess
CSF levels of FFA and specific severity degree of stroke. Evaluation of the prognostic
outcomes of those stroke patients used the modified Rankin scale scores at 90-days.
Logistic regression analysis analyzed the prognostic value of FFA. NIHSS score results
suggested a positive relationship between levels of CSF FFA levels and severity of
stroke. There was an obviously higher trend of CSF FFA levels in patients with CE
stroke than those of the non-CE stroke patients, with statistically difference (P < 0.05).
Further, CSF FFA levels were evidently lower in those 73 patients with favorable outcome
when compared to those with unfavorable outcomes [0.21(IQR, 0.11–0.28) mmol/L vs.
0.36 (IQR, 0.27–0.50) mmol/L, P < 0.0001, P < 0.0001]. Multivariate analysis results
after possible confounders adjustment indicated that there was an increased risk of
unfavorable outcome associated with CSF FFA levels ≥0.29 mmol/L (OR 5.12, 95%CI:
2.35–10.28; P < 0.0001). Collectively, CSF level of FFA at admission was suggested to
be a useful, independent short-term prognostic marker in Chinese patient with AIS.
Keywords: free fatty acid, acute ischemic stroke, cerebrospinal fluid, prognostic, Chinese, short-term
Introduction
Stroke is a leading cause of mortality and subsequent serious long-term disability among
survivors (Zhang and Zhang, 2014). During the recent decades, optimization of medical care
and allocation of health care resources play critical roles in maintaining and increasing the
survival outcomes of those patients, of which rapidly measurable biomarkers identiﬁcation are
extremely essential (Tu et al., 2013). Novel biomarkers have emerged to assist clinicians with
decision-making.
In the post absorptive state, free fatty acids (FFAs) are the preferred fuel source for the heart,
liver, and skeletal muscle, and yielding large quantities of adenosine triphosphate (ATP; Ebbert
and Jensen, 2013). FFA enters the circulatory system from lipolysis of triglycerides stored in
adipocytes, and the plasma FFA concentration is closely connected with lipid metabolism (Choi
et al., 2014). Elevated FFA concentration is linked to several risk factors for atherosclerosis,
including ischemic stroke risk (Yaemsiri et al., 2013). Interestingly, Seo et al. (2011) reported that
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elevated concentration of FFA might be one of the risk factors
that contribute to the development of cardioembolic (CE) stroke.
Pathological processes, including ischemia, and subarachnoid
hemorrhage could apparently lead to the increased cerebrospinal
ﬂuid (CSF) concentrations of FFAs, as supported by previous
animal designed experimental evidence (Gasparovic et al., 2001).
FFA accumulation begins within a few minutes of the onset
of insult and has been shown to remain elevated for hours
to days (Pilitsis et al., 2003). FFA accumulation can result in
an uncoupling of oxidative phosphorylation and the formation
of inﬂammatory by-products including reactive oxygen species
(Nakamura et al., 2009). Despite the well-documented increases
in FFAs in animal studies, FFA concentrations following stroke
in humans have not been well studied. To our knowledge,
there is still none relevant studies evaluated CSF FFA as a
prognostic marker after stroke in our Chinese population. Hence,
we conducted this prospective designed study for the purpose
of evaluating the prognostic value of CSF FFA levels in patients
conﬁrmed with acute ischemic stroke (AIS) in the Chinese
populations. In addition, whether FFA levels add signiﬁcant clue
to global prognostic indicator like NIHSS was also tested.
Materials and Methods
Prospectively, this study was performed within the department
of Emergency of Laiwu City People’s Hospital. From November,
2012 to September, 2014, all eligible patients with ﬁrst-ever
AIS were included in the present experiment. All patients were
examined by MRI with diﬀusion-weighted imaging (DWI).
And available data were carefully and completely recorded for
further investigation. Baseline characteristics, including ages,
genders, and history of conventional vascular risk factors such as
hypertension, diabetes mellitus, hypercholesterolemia, coronary
heart disease, atrial ﬁbrillation (AF) were obtained; previous
cigarette smoking habit was also recorded. Clinically, the use
of stroke scale-the National Institutes of Health Stroke Scale
(NIHSS) was applied for the assessment of stroke severity
executed by a neurologist in hospital (Brott et al., 1989). For a
reliable improvement of the classiﬁcation of stroke subgroups, the
Trial of Org 10172 in Acute Stroke Treatment (TOAST) criteria
was used (Adams et al., 1993). By applying the Oxfordshire
Community Stroke Project criteria, clinical syndrome of stroke
was determined (Bamford et al., 1991).
Additionally, exclusion criteria of this study were predeﬁned
as follows: (1) patients who were previously diagnosed with
malignancy, acute or chronic inﬂammatory diseases; (2) the
patients who presented to the hospital beyond 24 h following
stroke onset; (3) patients who without a brain imaging (MRI)
test. All enrolled subjects were gave written informed consent, or
by their family, and legal guardian. Institutional Review Board
of Laiwu City People’s Hospital was contacted to accept the
performance of this experiment.
The measurements of included subjects infarct volume was
according to the formula 0.5 × a × b × c (a, the maximal
longitudinal diameter, b, the maximal transverse diameter
perpendicular to a, and c, the number of 10-mm slices containing
infarct; Sims et al., 2009). Modiﬁed Rankin Scale (mRS) score
was used for the judgment of functional outcomes, which was
predeﬁned to be obtained on days 90. Detailed scores of this
criteria range from 0 to 6 blinded to FFA levels, where a
higher score indicate increasing severity (Bonita, 1988). Month
3 (90 days) was the primary end point of the study, focusing
on the exploration of the favorable functional outcome of stroke
patients. And the secondary end point was death due to any
causes within a 90-day follow-up. Two trained medical students
were selected to execute the assessment of outcomes of this trial,
through a structured telephone interview. And concordance on
most variables should be obtained by the two students. Reliability
analysis of the mRS (internal consistency) yielded Cronbach’s α
of 0.89 in this study.
Cerebrospinal ﬂuid samples of inclusions were obtained at
admission. CSF aliquots were centrifuged at 4000 rpm for
10 min and then frozen at −70◦C until assayed. The CSF FFA
was measured using an enzyme cycling method by OLYMPUS
AU2700 (OLYMPUS, Tokyo, Japan; intra-assay coeﬃcient of
variation [CV] 1.03–1.22%, inter-assay CV 1.32–1.45%). The
detection upper and lower limits were 3.00 and 0.01 mmol/L,
respectively. In order to test the relationship between FFA and
TABLE 1 | Baseline characteristics of acute ischemic stroke (AIS) patients
and normal cases.
Characteristics N = 238
Male sex (%) 145(60.9)
Age (years), median (IQR) 64(53–76)
Stroke severity, median NIHSS score (IQR) 8(5–13)
Infarct volume (mL, IQR) 25(8–44)




Coronary heart disease 31.1
Atrial fibrillation 24.8
Family history for stroke 19.7
Smoking habit 21.0
Laboratory CSF findings (median, IQR)
FFA (at admission, mmol L−1 ) 0.24(0.15–0.34)












IQR, interquartile range; TACS, total anterior circulation syndrome; LACS, lacunar
syndrome; PACS, partial anterior circulation syndrome; POCS, posterior circulation
syndrome; NIHSS, National Institutes of Health Stroke Scale; Hs-CRP, high
C-reactive protein.
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inﬂammation, CSF levels of high sensitivity C-reactive protein
(Hs-CRP) were also tested (Stearman and Southgate, 1994;
Takizawa et al., 2001; Is et al., 2007). And just in case, standard
for these undetectable levels was preset to equal to the lower
detection limit.
In this study, discrete variables are expressed as percentage
or frequencies and continuous variables as medians with
interquartile range (IQR). The application of the χ2 test (Chi-
square test) was used for the comparison of proportions, whereas
the comparison of continuous variables applied the Mann–
Whitney test. Spearman’s rank correlation was calculated to
assess the relationship between CSF FFA and others factors.
Further, multivariate logistic regression models was conducted
to assess the associations between FFA and NIHSS score, infarct
volume, as well as the inﬂuence of FFA levels on functional
outcome, after the adjustment with possible confounders such
as age, gender, time from onset to admission, stroke syndrome,
stroke etiology, vascular risk factors, and CSF levels of Hs-CRP.
The association between CSF FFA levels and AIS prognosis were
expressed as adjusted odds ratios (OR) and 95% conﬁdence
interval (95%CI). The receiver operating characteristic (ROC)
analysis was used to determine the optimal cut-oﬀ values from
diﬀerent predictive models for the comparison of diﬀerent
prognostic risk scores, combined with the calculation of area
under the curve (AUC), which was selected as a summary
measure over criteria and cut-point choices. Data were analyzed
with SPSS software version 19.0 (SPSS Inc., Chicago, IL, USA)
and the ROCR package (version 1.0-2; http://cran.r-project.org/).
The diﬀerence was statistically signiﬁcant when P < 0.05.
Results
In our study, CSF was collected after admission for standardized
measurement of FFA and Hs-CRP in 238 patients. Of the
238 patients, 145 (60.9%) were male with a median age of
64 years (IQR, 53–76). The median NIHSS score of patients
was eight points (IQR, 5–13) on the admission. A total of 59
(24.8%) patients were conﬁrmed as AF and 47 (19.7%) with a
family history of stroke diseases. For the purpose of this study,
CSF samples were drawn at admission [within 0–6 (n = 89),
6–12 (n = 95), and 12–24 (n = 54) hours from symptom
onset]. The primary baseline characteristics were illustrated in
Table 1.
The increase in CSF FFA levels correlated with increasing
disease severity of stroke based on the NIHSS score. The levels
of FFA in CSF were positively linked with the NIHSS score
(r = 0.397, P< 0.0001; Figure 1A) and Hs-CRP levels (r = 0.221,
P = 0.002). Multiple logistic regression analysis results showed
that a signiﬁcant positive trend was observed between the FFA
levels and the NIHSS score (P = 0.003). Additionally, CSF
FFA levels were also positively related to the infarct volume
(r = 0.296, P < 0.0001; Figure 1B). Meanwhile, the multiple
logistic regression analysis results indicated that a signiﬁcant
positive trend was persisted between the FFA levels and the
infarct volume (P = 0.009). Interestingly, we also found that
FFA levels were positively connected with the time from stroke
onset to admission (r = 0.186, P = 0.024). The correlation
between stroke category and FFA levels were assessed. CSF FFA
levels in patients with CE stroke were signiﬁcantly higher as
compared with non-CE stroke [0.37mmol/L (IQR, 0.27–0.45) vs.
0.15 mmol/L (IQR, 0.07–0.21); P < 0.0001]. Statistical analysis
revealed that there was no signiﬁcant inﬂuence of gender, age,
stroke syndrome, and other risk factors of stroke on FFA in
AIS patients (P > 0.05, respectively). Interesting, we found that
the patients with AF had elevated CSF FFA levels than others
[0.33 (IQR, 0.24–0.45) mmol/L vs. 0.24 (IQR, 0.13–0.33) mmol/L,
P < 0.0001].
At 90-day follow-up, 73 out of 238 patients (30.7%) showed an
unsatisfactory functional outcome and themedianmRS score was
4 (IQR, 3–6). Compared to patients with favorable outcomes, the
patients with unfavorable outcomes had elevated CSF FFA levels
[0.36 (IQR, 0.27–0.50) mmol/L vs. 0.21 (IQR, 0.11–0.28) mmol/L,
P< 0.0001; Figure 2A]. ROC curve showed that the optimal cut-
oﬀ value of CSF FFA levels was projected to be 0.29 mmol/L as
an predictor for functional outcome, which achieved a sensitivity
FIGURE 1 | Correlation between CSF FFA levels and others predictors. (A) Correlation between CSF FFA levels and the National Institutes of Health Stroke
Scale (NIHSS) score; (B) Correlation between CSF FFA levels and infract volume. CSF, cerebrospinal fluid; FFA, free fatty acid.
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FIGURE 2 | Distribution of CSF FFA levels in different groups.
(A) Distribution of CSF FFA levels in stroke patients with favorable and
unfavorable outcome. (B) Distribution of CSF FFA levels in patients with survival
and non-survival. The horizontal lines indicate medians and interquartile ranges
(IQRs) levels. P-values refer to Mann–Whitney U tests for differences between
groups. CSF, cerebrospinal fluid; FFA, free fatty acid.
of 84.5% and speciﬁcity of 80.8%, and the area below the ROC
curve was 0.825 (95%CI, 0.773–0.883). Based on the AUC of
0.825, FFA showed a markedly greater discriminatory ability
when compared with the Hs-CRP (AUC, 0.668; 95% CI, 0.601–
0.738; P < 0.001), the NIHSS score (AUC, 0.744; 95% CI,
0.667–0.811; P < 0.01), and infarct volume (AUC, 0.584; 95%
CI, 0.503–0.665; P < 0.0001). Further, FFA may improve the
patients’ NIHSS score (AUC of combined model, 0.858; 95% CI,
0.805–0.910; P < 0.001).
The study results also showed that CSF FFA levels
≥0.29 mmol/L was closely connected with an elevated risk
of unfavorable outcomes for AIS patients (unjusted OR 7.27,
95% CI: 3.94–13.41; P < 0.0001). Multivariate analysis indicated
that elevated risk of unfavorable outcomes was related to
CSF FFA levels ≥0.29 mmol/L (OR 5.12, 95%CI: 2.35–10.28;
P< 0.0001; Table 2). In addition, four other indicators, including
NIHSS score, age, infarct volume, and Hs-CRP, remained to be
signiﬁcant predictors for functional outcome.
Cerebrospinal ﬂuid free fatty acid levels in 29 patients who
died showed greater than twofold increase as compared to
patients who survived [0.47 (IQR, 0.30–0.59) mmol/L vs. 0.23
(IQR, 0.14–0.31) mmol/L, P< 0.0001; Figure 2B]. Similarly, FFA
level can still be acted as an independent indicator for predicting
the mortality (OR 6.13, 95% CI, 3.30–12.07), after multivariate
adjustment for the outcome predictors including age, NIHSS
score, and Hs-CRP.
TABLE 2 | Univariate and multivariate logistic regression analysis for outcome.
Predictor Univariate analysis Multivariate analysis
OR 95% CI P OR 95% CI P
FFA (≥0.29 mmol/L) 7.27 3.94–13.41 <0.0001 5.12 2.35–10.28 <0.0001
Age (increase per unit) 1.21 1.05–1.88 0.004 1.06 1.01–1.22 0.001
Hs-CRP (≥ 0.16 mg/dL) 2.22 1.45–3.13 <0.0001 1.76 1.33–2.43 <0.0001
Infarct volume (increase per unit) 1.18 1.10–1.32 0.003 1.15 1.06–1.29 0.009
NIHSS (increase per unit) 1.55 1.30–1.86 <0.001 1.31 1.10–1.48 <0.001
Hypertension 1.92 1.14–3.19 0.011 1.55 1.02–2.98 0.144
Atrial fibrillation 1.62 1.00–2.70 0.064 –
Hypercholesterolemia 0.78 0.48–1.27 0.323 –
Coronary heart disease 1.20 0.75–1.95 0.464 –
Small-vessel occlusive 0.61 0.21–1.80 0.376 –
Large-vessel occlusive 1.05 0.68–1.62 0.845 –
CE 1.12 0.74–1.69 0.742 –
TACS 1.81 1.41–3.54 0.532 –
PACS 1.78 1.21–3.99 0.743 –
LACS 0.35 0.12–1.02 0.054 –
POCS 0.66 0.29–1.48 0.302 –
OR, odds ratio; CI, confidence interval; Hs-CRP, high-sensitivity C-reactive protein; NIHSS, National Institutes of Health Stroke Scale; LACS, lacunar syndrome; PACS,
partial anterior circulation syndrome; POCS, posterior circulation syndrome; TACS, total anterior circulation syndrome.
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Discussion
Previous animal study has demonstrated that the up-regulated
levels of certain CSF biomarkers may reﬂect the pathological
activities in central nervous system (CNS), andmay be in relation
to ischemic diseases (Hjalmarsson et al., 2014). However, only
a few human clinical studies have assessed the associations of
the CSF biomarkers with stroke. Several studies have assessed
several peripheral indicators of brain damage, including amyloid
precursor protein metabolites (Selnes et al., 2010), YKL-40
(Kaynar et al., 2005), myelin basic protein (Lamers et al., 2003),
Neuron-speciﬁc enolase (Selakovic et al., 2005), protein S100B
(Brouns et al., 2010), glial ﬁbrillary acidic protein (Steiner
et al., 2006), and Monocyte chemoattractant protein-1 (Losy
and Zaremba, 2001). To our knowledge, we ﬁrstly evaluated the
accuracy and predictive value of CSF FFA levels to the functional
outcomes of AIS patients at 90-day after admission in Chinese
sample. Our primary ﬁnding was that CSF FFA level was a
meaningful and independent predicting indictor for functional
outcome 90-day after ischemic stroke, and CSF FFA levels
≥0.29 mmol/L were linked to a 5.12-fold increase in unfavorable
outcome. Importantly, FFA could improve prognostic value of
NIHSS score for clinical outcome and was a better prognostic
marker compared with other markers. Additionally, our study
results also indicated that elevated CSF FFA levels was implicated
in the increasing severity of stroke after accounting for the
NIHSS score, and also the CSF FFA levels were both positively
connected with the Hs-CRP levels in CSF and the infarct
volume.
Seo et al. (2011) reported that the baseline plasma level of
FFA in CE stroke patients was approximately 1.5-fold higher than
that of non-CE stroke patients. In line with the previous study,
we also found that CSF FFA levels in CE stroke patients were
signiﬁcantly higher as compared to non-CE stroke (P < 0.0001).
In another study, Pilitsis et al. (2003) found that up-regulation
CSF levels of polyunsaturated fatty acids (PUFAs) that obtained
within 2 days of insult were connected with a worse clinical
outcome at hospital discharge, after adjusting for the Glasgow
Outcome Scale (P < 0.01). However, the small sample (N = 25)
should be referred. In our study, we conﬁrmed above conclusion
in a larger sample.
Whether the high CSF FFA plays an independent role in
contributing the prognosis or just an epiphenomenon to disease
severity is uncertain. As we all know, a severe stroke is essentially
implicated with a poor outcome. Nevertheless, several other
reasons have been involved in the unfavorable outcome of
AIS patients with higher FFA levels. First, FFA may generate
arrhythmia. Numerous experimental studies have also suggested
the arrhythmogenicity of FFA (Oliver and Opie, 1994; Khawaja
et al., 2012). Previously, Seo et al. (2011) manifested that the
connection between FFA and CE stroke might result from the
association between FFA and AF. In ours study, we also found
that patients with AF had elevated CSF FFA levels. Second,
elevated FFA might have thrombogenicity in patients with CE
stroke (Seo et al., 2011). Consistent with this, animal studies have
demonstrated systemic thromboembolism after FFA infusion
(Connor et al., 1963), with activation of factor XII by stearic acids
postulated as a possible mechanism (Didisheim and Mibashan,
1963). Third, an increase of plasma FFA in stroke patients may
reﬂect a metabolic state of CE stroke attributed to AF. Finally,
the eﬀects of FFA on brain inﬂammation have been evaluated
(Gupta et al., 2012). Similarly, a positive correlation between
FFA and Hs-CRP levels (P = 0.002) was found in our study.
Dasu and Jialal (2011) concluded that FFA may aggravate the
expression of HG-induced Toll-like receptors (TLRs) and can
induce the production of monocytic cells with over superoxide
release, which may activate the NF-κB activity and also induced
pro-inﬂammatory factor release.
Several limitations of the current observational study should
be noted while interpreting our results. Firstly, in our study, we
did not measured the circulating CSF FFA levels, so it yielded
no exactly data about when and how long the FFA levels were
elevated in AIS patients. Nakano et al. (1990) observed an
increase in FFA concentrations in the gerbil brain following 5min
of ischemia. This was followed by a slow increase in FFA levels
that reached a peak at about 3 days and then declined once
again. Secondly, the measurements of FFA levels were conducted
after the stroke, which may not precisely reﬂect pre-stroke
exposure. Thirdly, the study population was only composed of
a single ethnic population. To better generalize our data, a long-
term prospective cohort study with a larger population may be
necessary. Lastly, the predictive values of circulating FFA levels on
long-term functional outcome of AIS patients were not evaluated
in this study protocol.
Summary
CSF level of FFA at admission was a useful and independent
short-term prognostic indicator in Chinese patient with AIS.
Further studies should be conducted to investigate the underlying
mechanism between CSF FFA levels and the poor outcome of
AIS. In this regard, the prognosis of stroke patients in China
may be improved after elucidate the underlying mechanisms, if
possible.
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